JPWO2019183148A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019183148A5 JPWO2019183148A5 JP2020551340A JP2020551340A JPWO2019183148A5 JP WO2019183148 A5 JPWO2019183148 A5 JP WO2019183148A5 JP 2020551340 A JP2020551340 A JP 2020551340A JP 2020551340 A JP2020551340 A JP 2020551340A JP WO2019183148 A5 JPWO2019183148 A5 JP WO2019183148A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- acceptable salt
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023195267A JP2024026104A (ja) | 2018-03-19 | 2023-11-16 | Ｋｖ７チャネル活性化剤の構成および使用方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862644932P | 2018-03-19 | 2018-03-19 | |
| US201862644902P | 2018-03-19 | 2018-03-19 | |
| US62/644,932 | 2018-03-19 | ||
| US62/644,902 | 2018-03-19 | ||
| US201862663438P | 2018-04-27 | 2018-04-27 | |
| US62/663,438 | 2018-04-27 | ||
| US201862697198P | 2018-07-12 | 2018-07-12 | |
| US62/697,198 | 2018-07-12 | ||
| PCT/US2019/023039 WO2019183148A1 (en) | 2018-03-19 | 2019-03-19 | Kv7 channel activators compositions and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023195267A Division JP2024026104A (ja) | 2018-03-19 | 2023-11-16 | Ｋｖ７チャネル活性化剤の構成および使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021518844A JP2021518844A (ja) | 2021-08-05 |
| JPWO2019183148A5 true JPWO2019183148A5 (https=) | 2023-01-06 |
| JP2021518844A5 JP2021518844A5 (https=) | 2023-01-06 |
| JP7757036B2 JP7757036B2 (ja) | 2025-10-21 |
Family
ID=67905138
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551340A Active JP7757036B2 (ja) | 2018-03-19 | 2019-03-19 | Ｋｖ７チャネル活性化剤の構成および使用方法 |
| JP2023195267A Pending JP2024026104A (ja) | 2018-03-19 | 2023-11-16 | Ｋｖ７チャネル活性化剤の構成および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023195267A Pending JP2024026104A (ja) | 2018-03-19 | 2023-11-16 | Ｋｖ７チャネル活性化剤の構成および使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US10851067B2 (https=) |
| EP (1) | EP3768677A4 (https=) |
| JP (2) | JP7757036B2 (https=) |
| KR (3) | KR102731128B1 (https=) |
| CN (6) | CN118955402A (https=) |
| AU (3) | AU2019239955B2 (https=) |
| BR (1) | BR112020018933A2 (https=) |
| CA (1) | CA3093976A1 (https=) |
| IL (2) | IL277419B2 (https=) |
| MX (2) | MX2020009693A (https=) |
| SG (1) | SG11202008030WA (https=) |
| WO (1) | WO2019183148A1 (https=) |
| ZA (1) | ZA202308070B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3572405T1 (sl) * | 2014-09-12 | 2023-12-29 | Biohaven Therapeutics Ltd. | Amidi benzoimidazol-1,2-il kot aktivatorji kanalov kv 7 |
| CN118955402A (zh) * | 2018-03-19 | 2024-11-15 | 诺普生物科学有限责任公司 | Kv7通道激活剂组合物和使用方法 |
| BR112022004847A2 (pt) * | 2019-09-17 | 2022-06-07 | Knopp Biosciences Llc | Método para tratar uma doença ou distúrbio de neurodesenvolvimento |
| CA3266454A1 (en) * | 2022-08-30 | 2024-03-07 | Biohaven Therapeutics Ltd. | POLYTHERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS |
| AU2023338196A1 (en) * | 2022-09-06 | 2025-04-10 | Biohaven Therapeutics Ltd. | Combination therapies including metal channel activators |
| KR20260049605A (ko) * | 2023-08-10 | 2026-04-14 | 바이오하벤 테라퓨틱스 리미티드 | Kv7.2/7.3 칼륨 채널 활성제의 서방형 제형 |
| IL326832A (en) * | 2023-09-15 | 2026-04-01 | Biohaven Therapeutics Ltd | Methods for treating epilepsy and related disorders using potent and selective potassium channel activators |
| WO2025103406A1 (zh) * | 2023-11-15 | 2025-05-22 | 南京明德新药研发有限公司 | 6并5杂芳基衍生物及其应用 |
| WO2025137661A1 (en) * | 2023-12-22 | 2025-06-26 | Biohaven Therapeutics Ltd. | Combination treatment of neurological disorders |
| US20260049061A1 (en) * | 2024-03-18 | 2026-02-19 | HUMANWELL PHARMACEUTICAL US, Inc. | Small molecules as kcnq2/3 (kv7.2/3) channel activators and their medical use thereof |
| WO2026042005A1 (en) | 2024-08-18 | 2026-02-26 | Biohaven Therapeutics Ltd. | Prodrugs of benzimidazol-1,2-yl amide compounds |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0772181B2 (ja) | 1989-06-26 | 1995-08-02 | 株式会社大塚製薬工場 | ベンズイミダゾール誘導体 |
| JPH0772181A (ja) | 1993-09-03 | 1995-03-17 | Advantest Corp | 電位波形測定方法および装置 |
| GB9413724D0 (en) | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
| US6855714B2 (en) | 2001-07-06 | 2005-02-15 | Schering Aktiengesellschaft | 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| SE0301701D0 (sv) | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| WO2007017764A2 (en) * | 2005-05-18 | 2007-02-15 | Neuraxon, Inc. | Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity |
| CN101516873A (zh) * | 2006-10-03 | 2009-08-26 | 神经研究公司 | 用作钾通道调节剂的吲唑基衍生物 |
| EP2186804B1 (en) | 2007-08-10 | 2015-06-17 | Nippon Soda Co., Ltd. | Nitrogen-containing heterocyclic compound and pest control agent |
| TWI482768B (zh) | 2007-11-22 | 2015-05-01 | Zenyaku Kogyo Kk | 雜環化合物之非晶質體、含有其之固體分散體、藥劑及其製法 |
| GB0723794D0 (en) | 2007-12-05 | 2008-01-16 | Lectus Therapeutics Ltd | Potassium ion channel modulators and uses thereof |
| AU2008343813B2 (en) | 2007-12-19 | 2012-04-12 | Amgen Inc. | Inhibitors of PI3 kinase |
| WO2010051819A1 (en) | 2008-11-10 | 2010-05-14 | Neurosearch A/S | Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| US8232273B2 (en) | 2008-12-19 | 2012-07-31 | Genentech, Inc. | Heterocyclic compounds and methods of use |
| CA2804165C (en) | 2010-07-08 | 2015-02-24 | Pfizer Inc. | Piperidinyl pyrimidine amides as kv7 potassium channel openers |
| CN103168032A (zh) | 2010-08-05 | 2013-06-19 | 安美基公司 | 抑制间变性淋巴瘤激酶的苯并咪唑和氮杂苯并咪唑化合物 |
| US9650376B2 (en) | 2013-03-15 | 2017-05-16 | Knopp Biosciences Llc | Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators |
| WO2015023958A1 (en) * | 2013-08-15 | 2015-02-19 | The University Of Kansas | Toll-like receptor agonists |
| SI3572405T1 (sl) | 2014-09-12 | 2023-12-29 | Biohaven Therapeutics Ltd. | Amidi benzoimidazol-1,2-il kot aktivatorji kanalov kv 7 |
| CN118955402A (zh) * | 2018-03-19 | 2024-11-15 | 诺普生物科学有限责任公司 | Kv7通道激活剂组合物和使用方法 |
| BR112022004847A2 (pt) * | 2019-09-17 | 2022-06-07 | Knopp Biosciences Llc | Método para tratar uma doença ou distúrbio de neurodesenvolvimento |
-
2019
- 2019-03-19 CN CN202410835028.0A patent/CN118955402A/zh active Pending
- 2019-03-19 AU AU2019239955A patent/AU2019239955B2/en active Active
- 2019-03-19 IL IL277419A patent/IL277419B2/en unknown
- 2019-03-19 BR BR112020018933-2A patent/BR112020018933A2/pt unknown
- 2019-03-19 CA CA3093976A patent/CA3093976A1/en active Pending
- 2019-03-19 US US16/358,642 patent/US10851067B2/en active Active
- 2019-03-19 KR KR1020207029659A patent/KR102731128B1/ko active Active
- 2019-03-19 KR KR1020247037753A patent/KR102868652B1/ko active Active
- 2019-03-19 CN CN202410805545.3A patent/CN118955400A/zh active Pending
- 2019-03-19 CN CN202410805542.XA patent/CN119118926A/zh active Pending
- 2019-03-19 CN CN201980033266.7A patent/CN112771039A/zh active Pending
- 2019-03-19 JP JP2020551340A patent/JP7757036B2/ja active Active
- 2019-03-19 CN CN202410840828.1A patent/CN118955403A/zh active Pending
- 2019-03-19 WO PCT/US2019/023039 patent/WO2019183148A1/en not_active Ceased
- 2019-03-19 KR KR1020257032902A patent/KR20250150168A/ko active Pending
- 2019-03-19 SG SG11202008030WA patent/SG11202008030WA/en unknown
- 2019-03-19 EP EP19772264.8A patent/EP3768677A4/en active Pending
- 2019-03-19 MX MX2020009693A patent/MX2020009693A/es unknown
- 2019-03-19 CN CN202410827103.9A patent/CN118955401A/zh active Pending
- 2019-03-19 IL IL310136A patent/IL310136A/en unknown
-
2020
- 2020-09-17 MX MX2023001153A patent/MX2023001153A/es unknown
- 2020-10-22 US US17/077,068 patent/US11261162B2/en active Active
-
2022
- 2022-01-07 US US17/570,536 patent/US11724990B2/en active Active
-
2023
- 2023-06-20 US US18/338,096 patent/US12286408B2/en active Active
- 2023-08-21 ZA ZA2023/08070A patent/ZA202308070B/en unknown
- 2023-11-16 JP JP2023195267A patent/JP2024026104A/ja active Pending
- 2023-11-17 AU AU2023266373A patent/AU2023266373B2/en active Active
-
2024
- 2024-04-17 AU AU2024202496A patent/AU2024202496A1/en active Pending
-
2025
- 2025-03-29 US US19/094,862 patent/US20260062389A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2019183148A5 (https=) | ||
| CA2440037A1 (en) | Benzimidazole derivatives for modulating the rage receptor | |
| JP2024026104A5 (https=) | ||
| JP2009538897A5 (https=) | ||
| CA2441565A1 (en) | Bisarylamines as potassium channel openers | |
| JP2010504346A5 (https=) | ||
| JP2005504736A5 (https=) | ||
| JP2010500376A5 (https=) | ||
| JPWO2019199972A5 (https=) | ||
| JP2018035197A5 (https=) | ||
| JP2011506438A5 (https=) | ||
| JP2002512954A5 (https=) | ||
| JP2015510941A5 (https=) | ||
| RU2006140989A (ru) | 2-пиридилзамещенные имидазолы как ингибиторы рецепторов alk4 | |
| RU2017134286A (ru) | Производное морфинана | |
| JP2021512959A (ja) | ピラゾロ［１，５−ａ］［１，３，５］トリアジン−２−アミン誘導体、その製造法、およびその医薬用途 | |
| JP2002535370A (ja) | 末梢型ベンゾジアゼピン受容体の機能不全に関連した疾患治療用薬剤の製造用のピリダジノ［４，５−ｂ］インドール−１−アセトアミド誘導体の使用 | |
| RU2005111590A (ru) | 2,4-замещенные индолы и их использование в качестве модуляторов 5-гт6 | |
| JP2005530779A5 (https=) | ||
| JP2019535812A5 (https=) | ||
| RU2016148170A (ru) | Фармакологически активные производные хиназолиндиона | |
| RU2014146509A (ru) | Ингибиторы кат ii | |
| RU2006138864A (ru) | Ингибиторы митотического кинезина | |
| JP2006501245A5 (https=) | ||
| JP2010523540A5 (https=) |